Behind Big Pharma’s layoffs — is there an end in sight?

[cafead]

via Industry layoffs surged last year, claiming about 14,000 jobs across biopharma. While many hoped 2024 would be a turning point, workforce cuts have continued and the worst might not be over, according to Arda Ural, EY Americas industry markets leader, health sciences and wellness.

article source